"Oral Anticoagulants May Be Harmful In Patients With AF On Dialysis" - Scott Buzby
Among patients with atrial fibrillation on long-term dialysis, oral anticoagulants were not associated with decreased risk for thromboembolism and some of them elevated risk for bleeding, according to researchers at the Icahn School of Medicine at Mount Sinai. “Our study did not reveal the efficacy to prevent stroke and/or systemic thromboembolism of apixaban 5 mg/2.5 mg against no anticoagulant, whereas it revealed less bleeding than warfarin,” said Toshiki Kuno, MD, PhD, resident in the department of medicine at the Icahn School of Medicine at Mount Sinai.He added, “Moreover, apixaban 5 mg twice daily was associated with a reduction in mortality compared with no anticoagulant.”
—Toshiki Kuno, MD, PhD, Resident, Department of Medicine, Icahn School of Medicine at Mount Sinai
After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing
Oct 30, 2024 View All Press Releases
Skipping Breakfast May Compromise the Immune System
Feb 23, 2023 View All Press Releases.jpg)
Mount Sinai Recruits Internationally Recognized Cardiovascular Immunology Researcher
Jul 21, 2021 View All Press Releases